{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:11:02Z","timestamp":1787505062615,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.amjcard.2005.09.060","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T16:48:38Z","timestamp":1129654118000},"page":"10-18","source":"Crossref","is-referenced-by-count":63,"special_numbering":"S1","title":["Drugs for Left Ventricular Remodeling in Heart Failure"],"prefix":"10.1016","volume":"96","author":[{"given":"Maria","family":"Frigerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Roubina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2005.09.060_bib1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"6 suppl","key":"10.1016\/j.amjcard.2005.09.060_bib3","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.cardfail.2004.09.008","article-title":"Basic mechanisms of left ventricular remodeling","volume":"10","author":"Mann","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2005.09.060_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carpath.2004.12.002","article-title":"Cardiac remodeling and failure","volume":"14","author":"Fedak","year":"2005","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib6","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1161\/01.CIR.96.9.2953","article-title":"Circulating cadiac troponin I in severe congestive heart failure","volume":"96","author":"Missov","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1054\/jcaf.2002.129280","article-title":"Cardiac myocyte remodeling in hypertrophy and progression to failure","volume":"8","author":"Gerdes","year":"2002","journal-title":"J Card Fail"},{"issue":"Suppl","key":"10.1016\/j.amjcard.2005.09.060_bib8","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1067\/mhj.2003.159","article-title":"Surrogate end points in heart failure trials","volume":"145","author":"Gheorghiade","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2005.09.060_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1054\/jcaf.2002.129289","article-title":"Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction","volume":"8","author":"Udelson","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2005.09.060_bib10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","article-title":"Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction","volume":"336","author":"Vasan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","article-title":"Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction","volume":"89","author":"St John Sutton","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib12","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0735-1097(00)00511-8","article-title":"Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials","volume":"35","author":"Quinones","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib14","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2003.12.053","article-title":"Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure","volume":"43","author":"Wong","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib16","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting ensyme inhibitors in cardiovascular disease","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2005.09.060_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib20","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.0000131449.94713.AD","article-title":"Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists","volume":"109","author":"Azizi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/hh0701.089175","article-title":"Enhanced angiotensin II activity in heart failure","volume":"88","author":"Opie","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2005.09.060_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/hrt.72.1.63","article-title":"Effect of captopril on functional mitral regurgitation in dilated heart failure","volume":"72","author":"Seneviratne","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.amjcard.2005.09.060_bib23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0002-9149(98)00623-7","article-title":"Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling","volume":"82","author":"Levine","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib24","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low-doses and high-doses of the angiotensin converting enzyme inhibitor lisinopril on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib27","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","article-title":"Valsartan benefits left ventricular structure and function in heart failure","volume":"40","author":"Wong","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of the metoprolol in idiopathic dilated cardiomyopathy (MDC) trial","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(97)80008-6","article-title":"Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS II)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib37","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.09.060_bib40","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/01.CIR.0000065187.80707.18","article-title":"\u03b2-blockers in chronic heart failure","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0735-1097(94)00543-Y","article-title":"Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade","volume":"25","author":"Hall","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0735-1097(02)01840-5","article-title":"Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure","volume":"39","author":"Zugck","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mhj.2002.121269","article-title":"Effects of bisoprolol fumarate on left ventricular size, function and exercise capacity in patients with heart failure","volume":"143","author":"Dubach","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2005.09.060_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1388-9842(03)00105-3","article-title":"Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure","volume":"5","author":"Waagstein","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2005.09.060_bib45","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","article-title":"Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure","volume":"83","author":"Lowes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:CARD.0000025756.32499.6f","article-title":"The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction","volume":"18","author":"Remme","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2005.09.060_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1067\/mhj.2001.116768","article-title":"Regression of left ventricular remodelling in chronic heart failure","volume":"142","author":"Khattar","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2005.09.060_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.80.3.551","article-title":"Long-term beta-blockade in dilated cardiomyopathy","volume":"80","author":"Waagstein","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib49","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/01.CIR.89.4.1632","article-title":"Dose response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy","volume":"89","author":"Bristow","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib50","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in patients with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cardfail.2003.10.002","article-title":"Chronic left ventricular failure in the community","volume":"10","author":"Cioffi","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2005.09.060_bib52","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.94.11.2793","article-title":"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure","volume":"94","author":"Packer","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib54","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib55","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2003-030373","article-title":"Aldosterone","volume":"88","author":"White","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2005.09.060_bib56","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0735-1097(00)00796-8","article-title":"Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"36","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib57","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(99)80686-9","article-title":"Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis","volume":"75","author":"Klappacher","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib59","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2003.05.016","article-title":"Cardiac resynchronization by pacing","volume":"94","author":"Boriani","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib61","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib62","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib63","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.09.060_bib64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2007-1013899","article-title":"Left ventricular aneurysm","volume":"37","author":"Dor","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2005.09.060_bib65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mtc.2001.111379","article-title":"Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery","volume":"121","author":"Di Donato","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2005.09.060_bib66","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0735-1097(01)01119-6","article-title":"Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction","volume":"37","author":"Athanasuleas","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2005.09.060_bib67","first-page":"S42","article-title":"Surgical left ventricle reconstruction, pathophysiologic insights, results and expectation from the STICH trial","volume":"26","author":"Menicanti","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"suppl 6","key":"10.1016\/j.amjcard.2005.09.060_bib68","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0003-4975(03)00463-6","article-title":"The cardiac support device and the myosplint","volume":"75","author":"Sabbah","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2005.09.060_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cardfail.2003.10.007","article-title":"Rationale, design and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York Heart Association class III-IV heart failure","volume":"10","author":"Mann","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2005.09.060_bib70","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0735-1097(02)01890-9","article-title":"Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure","volume":"39","author":"Saavedra","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"suppl A","key":"10.1016\/j.amjcard.2005.09.060_bib71","doi-asserted-by":"crossref","first-page":"142A","DOI":"10.1016\/S0735-1097(02)80623-4","article-title":"Efficacy trends with the Acorn cardiac support device","volume":"39","author":"Konertz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.09.060_bib72","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1053-2498(01)00773-2","article-title":"Myosplint implant and shape-change procedure","volume":"21","author":"Schenk","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.amjcard.2005.09.060_bib73","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1161\/01.CIR.0000090961.53902.99","article-title":"Left ventricular assist devices","volume":"108","author":"Stevenson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.09.060_bib74","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/01.CIR.98.22.2383","article-title":"Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure","volume":"98","author":"Mancini","year":"1998","journal-title":"Circulation"},{"issue":"3suppl","key":"10.1016\/j.amjcard.2005.09.060_bib75","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S0003-4975(00)02633-3","article-title":"Healing the heart with ventricular assist device therapy","volume":"71","author":"Young","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2005.09.060_bib76","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/hc3101.093903","article-title":"Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure","volume":"104","author":"Barbone","year":"2001","journal-title":"Circulation"},{"issue":"suppl","key":"10.1016\/j.amjcard.2005.09.060_bib77","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0003-4975(03)00460-0","article-title":"Bridge to recovery with use of left ventricular assist device and clenbuterol","volume":"75","author":"Hon","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2005.09.060_bib78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1071-9164(03)00592-X","article-title":"Recovery from heart failure with circulatory assist","volume":"9","author":"Reinlib","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2005.09.060_bib79","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/01.CIR.0000161276.09685.4A","article-title":"Patient selection for cardiac resynchronization therapy","volume":"111","author":"Strickberger","year":"2005","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905016000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905016000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T14:24:56Z","timestamp":1548080696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914905016000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002914905016000"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.09.060","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}